Home › NDC Lookup › Ingredients › Gabapentin › 65841-0705-05
Gabapentin 600 mg Tablet, Film Coated, 500-count — NDC 65841-0705-05 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Gabapentin 600 mg Tablet, Film Coated, 500-count — NDC 65841-705-05 (Billing 65841-0705-05)

by Zydus Lifesciences Limited · 500 TABLET, FILM COATED in 1 BOTTLE

This is a package of 500 tablets of Gabapentin 600 mg Tablet, Film Coated from Zydus Lifesciences Limited, marketed since Oct 2012 and currently FDA-listed.

NDC 65841-0705-05
🏷️ FDA NDC (as labeled) 65841-705-05 billing pads the product segment with a zero
This package
Contains500-count Pack sizes3 compare ↓
Also priced by: Part D plans $0.1683/unit — full pricing hub ↓
Product page 65841-0705-01 Also comes in: 100 tablets 65841-705-01 1000 tablets 65841-705-10
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 65841-705-05 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
65841 labeler · 705 product · 05 package
Package marketed since
Oct 16, 2012
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC)
0365841705010
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Gabapentin (different manufacturers) — 5 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Oct 10, 2025 — Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity . (The Harvard Drug Group LLC) · FDA recall D-0031-2026
Class II · Jun 19, 2025 — Defective container; blister packaging inadequately sealed. (The Harvard Drug Group LLC) · FDA recall D-0508-2025
Class II · Mar 13, 2025 — CGMP Deviations (Glenmark Pharmaceuticals Inc., USA) · FDA recall D-0320-2025
Class III · Mar 4, 2025 — Cross Contamination (SUN PHARMACEUTICAL INDUSTRIES INC) · FDA recall D-0312-2025
Class III · Mar 4, 2025 — Cross Contamination (SUN PHARMACEUTICAL INDUSTRIES INC) · FDA recall D-0311-2025
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 65841-705-05
Product NDC 65841-705
11-digit billing NDC 65841070505
RxCUI 310433, 310434
UNII 6CW7F3G59X
UPC 0365841705010
Application # ANDA078926
SPL Set ID b033c169-4943-4ad9-ace0-7e4a1f0dc100
Physiologic effect Decreased Central Nervous System Disorganized Electrical Activity
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2012-10-16
Route ORAL
Dosage form TABLET, FILM COATED
Substance GABAPENTIN
TE code (Orange Book) AB1 · RLD · RS
Quick answers
  • RxCUI (RxNorm): 310433
Why two NDCs? The FDA registers this code as 65841-705-05 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 65841-0705-05. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Gabapentinoids class.

Drug family (ATC) Gabapentinoids
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It manages nerve pain after shingles (postherpetic neuralgia). Many gabapentin products are also add-on treatment for partial seizures in epilepsy. Horizant is also used for restle...
  • Be careful. Gabapentin can make you sleepy and dizzy and may impair driving. Don't drive or use heavy machinery until you know how it affects you, since it can be hard to judge you...
  • Don't stop it on your own. For seizures, stopping suddenly can increase seizure frequency. Reports also describe withdrawal symptoms such as anxiety, trouble sleeping, nausea and s...
  • Missed-dose advice depends on the product. With Horizant, for restless legs syndrome take the next dose the following day, and for postherpetic neuralgia skip it and take the next...
📖 Read our full Gabapentin guide →
1
Nutrient depletion considerations

Gabapentin may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Gabapentin nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.1683 $84.15 / 500 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
65841-0705-01 65841-705-01 Main listing 100 TABLET, FILM COATED in 1 BOTTLE 2012-10-16 — Active
65841-0705-05 You're viewing this 500 TABLET, FILM COATED in 1 BOTTLE 2012-10-16 — Active
65841-0705-10 65841-705-10 1000 TABLET, FILM COATED in 1 BOTTLE 2012-10-16 — Active

You're viewing one of 3 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 500-count package — 500 tablet, film coated in 1 bottle.
How does this package differ from NDC 65841-0705-01?
Both are Gabapentin 600 mg Tablet, Film Coated — the drug itself is identical. This page's package is the 500-count one, while NDC 65841-0705-01 is the 100 tablets package.
What NDC number is used to bill for this package of Gabapentin 600 mg Tablet, Film Coated?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Gabapentin 600 mg 00904-6823-61 Major 1 tablet $0.064 AB1 Availability likely —
Gabapentin 600 mg 16571-0226-01 Rising 100 tablets $0.064 AB1 Availability likely —
Gabapentin 600 mg 16714-0330-01 NorthStar 100 tablets $0.064 AB1 Availability likely —
Gabapentin 600 mg 31722-0166-01 Camber 100 tablets $0.064 AB1 Availability likely —
Gabapentin 600 mg 50228-0177-01 ScieGen 100 tablets $0.064 AB1 Availability likely —
Gabapentin 600 mg 50268-0325-15 AvPAK 1 tablet $0.064 AB1 Availability likely —
Gabapentin 600 mg 60687-0507-01 American 1 tablet $0.064 AB1 Availability likely —
Gabapentin 600 mg 64380-0727-01 Strides 100 tablets $0.064 AB1 Availability likely —
Gabapentin 600 mg 65862-0523-01 Aurobindo 100 tablets $0.064 — Availability likely —
Gabapentin 600 mg 67877-0428-01 Ascend 100 tablets $0.064 AB1 Availability likely —
Gabapentin 600 mg 68001-0411-00 BluePoint 100 tablets $0.064 AB1 Availability likely —
Gabapentin 600 mg 68094-0589-50 Precision 100 tablets $0.064 AB1 Availability likely —
Gabapentin 600 mg 68382-0204-01 Zydus 100 tablets $0.064 AB1 Availability likely —
Gabapentin 600 mg 68462-0126-01 Glenmark 100 tablets $0.064 AB1 Availability likely —
Gabapentin 600 mg 69367-0346-05 Westminster 500 tablets $0.064 AB1 Availability likely —
Gabapentin 600 mg 70010-0227-01 Granules 100 tablets $0.064 AB1 Availability likely —
Gabapentin 600 mg 71093-0111-04 ACI 100 tablets $0.064 AB1 Discontinued —
Gabapentin 600 mg 76282-0405-01 Exelan 100 tablets $0.064 — Availability likely —
Gabapentin 600 mg 76282-0706-05 Exelan 500 tablets $0.064 AB1 Availability likely —
Gabapentin 600 mg 82009-0071-05 QUALLENT 500 tablets $0.064 AB1 Availability likely —
Gabapentin 600 mg 83301-0001-01 Mullan 100 tablets $0.064 AB1 Availability likely —
Gabapentin 600 mg 68094-0069-61 Precision 10 tablets $0.064 AB1 Availability likely —
gabapentin 600 mg 62756-0202-01 Sun 100 tablets $0.068 — FDA listed —
Gabapentin 600 mg 51224-0021-50 TAGI 100 tablets $0.098 AB1 Discontinued —
Gabapentin 600 mg 31722-0092-90 Camber 90 tablets $1.025 AB2 Availability likely —
Gabapentin 600 mg 42806-0657-09 Epic 90 tablets $1.025 AB2 Availability likely —
Gralise 600 mg 52427-0806-90 Almatica 90 tablets $10.153 AB2 Availability likely —
Neurontin 600 mg 00071-0513-24 Parke-Davis 100 tablets $14.084 AB1 Discontinued —
Neurontin 600 mg 58151-0284-01 Viatris 100 tablets $14.119 AB1 Availability likely —
Gabapentin 600 mg 42385-0979-01 Laurus 100 tablets — AB1 FDA listed —
Gabapentin 600 mg 50090-6854-00 A-S 90 tablets — AB1 FDA listed —
Gabapentin 600 mg 50090-6855-00 A-S 90 tablets — AB1 FDA listed —
Gabapentin 600 mg 50090-7268-00 A-S 90 tablets — AB1 FDA listed —
Gabapentin 600 mg 50090-7269-00 A-S 90 tablets — AB1 FDA listed —
Gabapentin 600 mg 50090-7714-00 A-S 90 tablets — AB1 FDA listed —
Gabapentin 600 mg 50090-7715-00 A-S 90 tablets — AB1 FDA listed —
Gabapentin 600 mg 55154-3357-00 Cardinal 1 tablet — AB1 FDA listed —
Gabapentin 600 mg 55154-8189-00 Cardinal 1 tablet — AB1 FDA listed —
Gabapentin 600 mg 55289-0959-30 PD-Rx 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 58118-0166-08 Clinical 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 60760-0066-60 St. 60 tablets — AB1 Discontinued —
Gabapentin 600 mg 60760-0743-90 St. 90 tablets — AB1 FDA listed —
Gabapentin 600 mg 60760-0987-90 St. 90 tablets — AB1 FDA listed —
Gabapentin 600 mg 63187-0057-00 Proficient 100 tablets — AB1 FDA listed —
Gabapentin 600 mg 63187-0785-00 Proficient 100 tablets — — FDA listed —
Gabapentin 600 mg 63629-3063-00 Bryant 45 tablets — AB1 FDA listed —
Gabapentin 600 mg 63629-7307-01 Bryant 90 tablets — AB1 FDA listed —
Gabapentin 600 mg 63629-8491-01 Bryant 500 tablets — AB1 FDA listed —
Gabapentin 600 mg 63629-8492-01 Bryant 100 tablets — AB1 FDA listed —
Gabapentin 600 mgthis 65841-0705-05 Zydus 500 tablets — AB1 FDA listed —
Gabapentin 600 mg 67046-1535-03 Coupler 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 68071-3445-03 NuCare 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 68071-3783-09 NuCare 90 tablets — AB1 FDA listed —
Gabapentin 600 mg 68788-8476-01 Preferred 100 tablets — AB1 FDA listed —
Gabapentin 600 mg 68788-8488-01 Preferred 100 tablets — AB1 FDA listed —
Gabapentin 600 mg 69097-0812-02 Cipla 30 tablets — — FDA listed —
Gabapentin 600 mg 70518-2098-00 REMEDYREPACK 30 tablets — AB1 Discontinued —
Gabapentin 600 mg 70518-2356-00 REMEDYREPACK 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 70518-2616-03 REMEDYREPACK 30 tablets — AB1 Discontinued —
Gabapentin 600 mg 70518-2842-00 REMEDYREPACK 28 tablets — AB1 Discontinued —
Gabapentin 600 mg 70518-4532-00 REMEDYREPACK 1 tablet — AB1 FDA listed —
Gabapentin 600 mg 71205-0457-30 Proficient 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 71205-0533-30 Proficient 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 71205-0931-00 Proficient 100 tablets — AB1 FDA listed —
Gabapentin 600 mg 71335-1026-01 Bryant 90 tablets — AB1 Discontinued —
Gabapentin 600 mg 71335-1132-00 Bryant 28 tablets — AB1 Discontinued —
Gabapentin 600 mg 71335-1200-00 Bryant 28 tablets — AB1 FDA listed —
Gabapentin 600 mg 71335-1287-00 Bryant 28 tablets — AB1 FDA listed —
Gabapentin 600 mg 71335-2048-01 Bryant 90 tablets — AB1 FDA listed —
Gabapentin 600 mg 71335-2281-01 Bryant 500 tablets — AB1 FDA listed —
Gabapentin 600 mg 71335-2701-00 Bryant 28 tablets — AB1 FDA listed —
Gabapentin 600 mg 71335-2719-01 Bryant 90 tablets — AB1 FDA listed —
Gabapentin 600 mg 71335-3060-00 Bryant 28 tablets — AB1 FDA listed —
Gabapentin 600 mg 71335-3143-01 Bryant 90 tablets — AB1 FDA listed —
Gabapentin 600 mg 71610-0044-30 Aphena 30 tablets — AB1 FDA listed —
gabapentin 600 mg 71610-0069-45 Aphena 45 tablets — — FDA listed —
Gabapentin 600 mg 71610-0621-15 Aphena 15 tablets — AB1 FDA listed —
Gabapentin 600 mg 71610-0767-30 Aphena 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 71610-0777-30 Aphena 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 72162-1530-01 Bryant 100 tablets — AB1 FDA listed —
Gabapentin 600 mg 72162-2141-01 Bryant 100 tablets — AB1 FDA listed —
Gabapentin 600 mg 72189-0313-60 Directrx 60 tablets — AB1 FDA listed —
Gabapentin 600 mg 72189-0471-30 Direct_Rx 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 72789-0127-30 PD-Rx 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 72865-0255-05 XLCare 500 tablets — AB1 FDA listed —
Gabapentin 600 mg 72888-0131-00 Advagen 1000 tablets — AB1 FDA listed —
Gabapentin 600 mg 76420-0235-12 Asclemed 120 tablets — AB1 FDA listed —
Gabapentin 600 mg 76420-0836-01 Asclemed 100 tablets — AB1 FDA listed —
Gabapentin 600 mg 77771-0177-05 Radha 500 tablets — AB1 FDA listed —
Gabapentin 600 mg 80425-0097-01 Advanced 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 80425-0201-01 Advanced 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 82619-0145-01 Creekwood 100 tablets — AB1 FDA listed —
Gabapentin 600 mg 82804-0015-30 Proficient 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 82804-0193-30 Proficient 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 82804-0210-90 Proficient 90 tablets — AB1 FDA listed —
Gabapentin 600 mg 83008-0063-60 Quality 60 tablets — AB1 Discontinued —
Gabapentin 600 mg 87441-0036-01 Unit 30 tablets — AB1 FDA listed —
gabapentin 600 mg 50228-0524-05 ScieGen 500 tablets — AB2 FDA listed —
gabapentin 600 mg 68382-0607-05 Zydus 500 tablets — AB2 FDA listed —
gabapentin 600 mg 70771-1862-04 Zydus 100 tablets — AB2 FDA listed —
Gabapentin 600 mg 85534-0009-00 HAWAII 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 67046-1086-03 Coupler 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 67046-1233-03 Coupler 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 85509-1166-03 PHOENIX 30 tablets — AB1 FDA listed —
Gabapentin 600 mg 58118-2126-08 Clinical 30 tablets — AB1 FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2012
On the market since
Oct 2012
📍
2026
Currently FDA-listed
14 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color White
ShapeOval
ImprintZE71
Size20 mm
ScoringScored — splits in 2
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Gabapentin inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII D9C330MD8B
    Copovidone is a synthetic polymer made by combining two types of plastic-like molecules. It acts as a binder and film-former to help hold tablet ingredients together and improve how the medicine dissolves in your body.
  • UNII 2165RE0K14
    A plant-based thickener made from cellulose that helps control how quickly the medicine dissolves and releases its active ingredient. It also binds ingredients together and improves the tablet's texture and handling during manufacturing.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 3OWL53L36A
    A natural sugar alcohol derived from seaweed or synthesized in the lab. It's used as a filler to add bulk, a sweetener in sugar-free formulas, and a disintegrant to help tablets break apart in the stomach.
  • UNII TUF2IVW3M2
    Poloxamer 407 is a synthetic polymer made from ethylene oxide and propylene oxide. In medicines, it acts as a thickener, emulsifier, and solubilizer to help mix ingredients and create the right texture.
  • UNII FZ989GH94E
    Povidone is a synthetic polymer made from a plastic-like material. It acts as a binder to hold tablet ingredients together and as a disintegrant to help the tablet break apart in your stomach so the medicine can be absorbed.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.

7 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerZydus Lifesciences Limited
Application holderZYDUS PHARMACEUTICALS USA INC
FDA applicationANDA078926 (ANDA)
Labeler code65841
First marketedOct 2012
Product typeHuman Prescription Drug
Portfolio720 products on file

More NDCs from Zydus Lifesciences Limited labeler code 65841

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
💬 Medication Guide 📄 Package Label / Principal Display Panel
💬 Medication Guide 8 words ▾

Manufactured by: Cadila Heathcare Ltd. India

SPL MEDGUIDE

📄 Package Label / Principal Display Panel 42 words ▾

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 65841-705-01 in bottle of 100 tablets Gabapentin Tablets USP, 600 mg R x only 100 tablets NDC 65841-706-01 in bottle of 100 tablets Gabapentin Tablets USP, 800 mg R x only 100 tablets Gabapentin tablets Gabapentin tablets

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Gabapentin — the program that covers self-administered drugs. 41 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Gabapentin. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$151.2M
Claims incl. refills
8.9M
Beneficiaries
5.1M
Spend / beneficiary
$29.73
Spend / claim
$16.90
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Zydus Lifesciences Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 100 tablets (65841-0705-01), 1000 tablets (65841-0705-10). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Zydus Lifesciences Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 65841-0695-01 · Zydus 65841-0706-01 · Zydus →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.